on Gemina Laboratories Ltd. (CVE:GLAB)
Gemina Laboratories Ltd. Announces Delisting from the CSE
Gemina Laboratories Ltd. has announced its decision to voluntarily delist its common shares from the Canadian Securities Exchange (CSE). The delisting will take effect at the close of trading on March 27, 2026, following approval from its disinterested shareholders during the annual general meeting on March 13, 2026. Despite the delisting, Gemina will remain a reporting issuer in Alberta, British Columbia, and Ontario.
The decision to delist is based on an evaluation of Gemina's operational needs, trading volumes, and associated costs of maintaining a CSE listing. The company considers this move beneficial for both the company and its shareholders, encouraging them to consult investment advisors regarding the implications.
Additionally, Dr. James Tansey has been appointed as the new Chairman of the Board. This leadership change, noted by CEO Rob Greene, marks a period of rebuilding for the company.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Gemina Laboratories Ltd. news